ApprovalTrail

Ingredient

Methotrexate

Products in Health Canada’s databases that list Methotrexate as a medicinal or active ingredient. Its salts and forms that the databases name on their own have their own pages.

Also listed as “Methotrexate (Methotrexate Sodium)” (76); “Methotrexate (Methotrexate Disodium)” (8). How names are joined

Drug products
91
60 authorized now
Natural health products
0
0 active licences
Notices of Compliance
51
Products in all
91

Drug products

Authorized products first.

NameDINStatus
ACH-METHOTREXATE (2.5 MG)Accord Healthcare Inc · Status since Oct 202102509067Marketed
APO-METHOTREXATE (2.5 MG)Apotex Inc. · Status since Jul 202102182963Marketed
AURO-METHOTREXATE (2.5 MG)Auro Pharma Inc. · Status since Feb 202302524023Marketed
JAMP METHOTREXATE TABLETS (10 MG)JAMP Pharma Corporation · Status since Jun 202502553740Marketed
M-METHOTREXATE (2.5 MG)Mantra Pharma Inc. · Status since Apr 202402534916Marketed
METHOFILL SELF-DOSE INJECTOR (10 MG)Accord Healthcare Inc · Status since Jul 202502530775Marketed
METHOFILL SELF-DOSE INJECTOR (12.5 MG)Accord Healthcare Inc · Status since Jul 202502530783Marketed
METHOFILL SELF-DOSE INJECTOR (15 MG)Accord Healthcare Inc · Status since Jul 202502530791Marketed
METHOFILL SELF-DOSE INJECTOR (17.5 MG)Accord Healthcare Inc · Status since Jul 202502530805Marketed
METHOFILL SELF-DOSE INJECTOR (20 MG)Accord Healthcare Inc · Status since Jul 202502530813Marketed
METHOFILL SELF-DOSE INJECTOR (22.5 MG)Accord Healthcare Inc · Status since Jul 202502530848Marketed
METHOFILL SELF-DOSE INJECTOR (25 MG)Accord Healthcare Inc · Status since Jul 202502530856Marketed
METHOTREXATE INJECTION BP (25 MG)Accord Healthcare Inc · Status since Aug 201902327236Marketed
METHOTREXATE INJECTION BP (25 MG)Accord Healthcare Inc · Status since Oct 202002464365Marketed
METHOTREXATE INJECTION BP (25 MG)Accord Healthcare Inc · Status since Apr 201902474735Marketed
METHOTREXATE INJECTION BP (25 MG)Accord Healthcare Inc · Status since Apr 201902474891Marketed
METHOTREXATE INJECTION USP (25 MG)Pfizer Canada Ulc · Status since Aug 201802182777Marketed
METHOTREXATE INJECTION USP (10 MG)Pfizer Canada Ulc · Status since Jun 201702182947Marketed
METHOTREXATE INJECTION USP (25 MG)Pfizer Canada Ulc · Status since Jun 201702182955Marketed
METHOTREXATE INJECTION USP (25 MG)Pfizer Canada Ulc · Status since Apr 201802182971Marketed
METHOTREXATE INJECTION, BP (7.5 MG)Pharmascience Inc. · Status since Sep 202402422166Marketed
METHOTREXATE INJECTION, BP (10 MG)Pharmascience Inc. · Status since Sep 202402422174Marketed
METHOTREXATE INJECTION, BP (15 MG)Pharmascience Inc. · Status since Sep 202402422182Marketed
METHOTREXATE INJECTION, BP (20 MG)Pharmascience Inc. · Status since Sep 202402422190Marketed
METHOTREXATE INJECTION, BP (25 MG)Pharmascience Inc. · Status since Sep 202402422204Marketed
METHOTREXATE SODIUM INJECTION (25 MG)Teva Canada Limited · Status since Aug 201702099705Marketed
METHOTREXATE SUBCUTANEOUS (10 MG)Accord Healthcare Inc · Status since Oct 202502491281Marketed
METHOTREXATE SUBCUTANEOUS (12.5 MG)Accord Healthcare Inc · Status since Oct 202502491303Marketed
METHOTREXATE SUBCUTANEOUS (15 MG)Accord Healthcare Inc · Status since Jun 202002491311Marketed
METHOTREXATE SUBCUTANEOUS (17.5 MG)Accord Healthcare Inc · Status since Feb 202002491338Marketed
METHOTREXATE SUBCUTANEOUS (20 MG)Accord Healthcare Inc · Status since Feb 202002491346Marketed
METHOTREXATE SUBCUTANEOUS (22.5 MG)Accord Healthcare Inc · Status since Feb 202002491354Marketed
METHOTREXATE SUBCUTANEOUS (25 MG)Accord Healthcare Inc · Status since Feb 202002491362Marketed
METHOTREXATE TABLETS, USP (10 MG)Pfizer Canada Ulc · Status since Aug 201702182750Marketed
METOJECT SUBCUTANEOUS (12.5 MG)Medexus Pharmaceuticals Inc. · Status since Sep 201902454750Marketed
METOJECT SUBCUTANEOUS (17.5 MG)Medexus Pharmaceuticals Inc. · Status since Dec 201602454769Marketed
METOJECT SUBCUTANEOUS (22.5 MG)Medexus Pharmaceuticals Inc. · Status since Dec 201602454777Marketed
METOJECT SUBCUTANEOUS (10 MG)Medexus Pharmaceuticals Inc. · Status since Sep 201902454831Marketed
METOJECT SUBCUTANEOUS (15 MG)Medexus Pharmaceuticals Inc. · Status since Nov 201802454858Marketed
METOJECT SUBCUTANEOUS (20 MG)Medexus Pharmaceuticals Inc. · Status since Dec 201602454866Marketed
METOJECT SUBCUTANEOUS (25 MG)Medexus Pharmaceuticals Inc. · Status since Dec 201602454874Marketed
PMS-METHOTREXATE (2.5 MG)Pharmascience Inc. · Status since Oct 201802170698Marketed
PMS-METHOTREXATE INJECTION (10 MG)Pharmascience Inc. · Status since Mar 202402539608Marketed
PMS-METHOTREXATE INJECTION (12.5 MG)Pharmascience Inc. · Status since Mar 202402539616Marketed
PMS-METHOTREXATE INJECTION (15 MG)Pharmascience Inc. · Status since Mar 202402539624Marketed
PMS-METHOTREXATE INJECTION (17.5 MG)Pharmascience Inc. · Status since Mar 202402539632Marketed
PMS-METHOTREXATE INJECTION (20 MG)Pharmascience Inc. · Status since Mar 202402539640Marketed
PMS-METHOTREXATE INJECTION (22.5 MG)Pharmascience Inc. · Status since Mar 202402539659Marketed
PMS-METHOTREXATE INJECTION (25 MG)Pharmascience Inc. · Status since Mar 202402539667Marketed
PMS-METHOTREXATE TABLETS (10 MG)Pharmascience Inc. · Status since Nov 202502561956Marketed
AURO-METHOTREXATE TABLETS (10 MG)Auro Pharma Inc. · Status since Jan 202602448165Approved
EUGIA-METHOTREXATE (2.5 MG)Eugia Pharma Inc. · Status since Mar 202402546515Approved
JAMP METHOTREXATE (2.5 MG)JAMP Pharma Corporation · Status since Nov 202502562979Approved
METHOFILL SELF-DOSE INJECTOR (7.5 MG)Accord Healthcare Inc · Status since Sep 202202530767Approved
METHOTREXATE (2.5 MG)Apotex Inc. · Status since Mar 201902283697Approved
METHOTREXATE INJECTION BP (25 MG)Uman Pharma Inc · Status since Sep 200902333023Approved
METHOTREXATE INJECTION, USP (25 MG)Strides Pharma Canada Inc · Status since Oct 202402417626Dormant
METHOTREXATE SUBCUTANEOUS (7.5 MG)Accord Healthcare Inc · Status since Aug 201902491273Approved
METHOTREXATE TABLETS, USP (10 MG)Pfizer Canada Ulc · Status since Dec 202502562839Approved
METOJECT SUBCUTANEOUS (7.5 MG)Medexus Pharmaceuticals Inc. · Status since May 201602454823Approved
JAMP-METHOTREXATE (25 MG)JAMP Pharma Corporation · Status since Nov 202202419173Cancelled Post Market
METHOTREXATE (25 MG)Pfizer Canada Ulc · Status since May 201102170671Cancelled Post Market
METHOTREXATE DBL INJ 10MG/ML (10 MG)David Bull Laboratories (Pty) Ltd. · Status since Aug 199700614335Cancelled Post Market
METHOTREXATE DBL INJ 2.5MG/ML (2.5 MG)David Bull Laboratories (Pty) Ltd. · Status since Aug 199800614327Cancelled Post Market
METHOTREXATE DBL INJ 25MG/ML (25 MG)David Bull Laboratories (Pty) Ltd. · Status since Aug 199800614343Cancelled Post Market
METHOTREXATE INJECTION USP (25 MG)Sandoz Canada Inc. · Status since Jul 202302398427Cancelled Post Market
METHOTREXATE PF/SA INJECTION (25 MG)Sandoz Canada Inc. · Status since Aug 201802377624Cancelled Pre Market
METHOTREXATE SOD INJ 25MG/ML USP (25 MG)David Bull Laboratories (Pty) Ltd. · Status since Aug 199802084481Cancelled Post Market
METHOTREXATE SODIUM INJ 20MG (20 MG)Lederle Cyanamid Canada Inc. · Status since Aug 199700410195Cancelled Post Market
METHOTREXATE SODIUM INJ 25.0MG/ML (25 MG)Lederle Cyanamid Canada Inc. · Status since Aug 199700321397Cancelled Post Market
METHOTREXATE SODIUM INJ 25MG/ML USP (25 MG)David Bull Laboratories (Pty) Ltd. · Status since Aug 199901911457Cancelled Post Market
METHOTREXATE SODIUM INJECTION USP (25 MG)Pfizer Canada Ulc · Status since Aug 200602161168Cancelled Post Market
METHOTREXATE TAB 2.5MG (2.5 MG)Lederle Cyanamid Canada Inc. · Status since Aug 199700014915Cancelled Post Market
METHOTREXATE TAB 2.5MG USP (2.5 MG)David Bull Laboratories (Pty) Ltd. · Status since Aug 200000632619Cancelled Post Market
METHOTREXATE-LIQ IM IV IAR INT IVR 25MG/ML (25 MG)Wyeth-Ayerst Canada Inc. · Status since Sep 200102170663Cancelled Post Market
METHOTREXATE-PWS IM IV IAR INT IVR 20MG/VIAL (20 MG)Wyeth-Ayerst Canada Inc. · Status since May 200102170655Cancelled Post Market
METOJECT (20 MG)Medexus Pharmaceuticals Inc. · Status since May 201702304767Cancelled Post Market
METOJECT (7.5 MG)Medexus Pharmaceuticals Inc. · Status since Jun 202202320029Cancelled Post Market
METOJECT (10 MG)Medexus Pharmaceuticals Inc. · Status since Apr 202002320037Cancelled Post Market
METOJECT (15 MG)Medexus Pharmaceuticals Inc. · Status since Jul 201902320045Cancelled Post Market
METOJECT (25 MG)Medexus Pharmaceuticals Inc. · Status since May 201702320053Cancelled Post Market
NORDIMET (7.5 MG)Nordic Group B.V. · Status since Mar 202602546531Cancelled Post Market
NORDIMET (10 MG)Nordic Group B.V. · Status since Mar 202602546558Cancelled Post Market
NORDIMET (12.5 MG)Nordic Group B.V. · Status since Mar 202602546566Cancelled Pre Market
NORDIMET (15 MG)Nordic Group B.V. · Status since Mar 202602546574Cancelled Post Market
NORDIMET (17.5 MG)Nordic Group B.V. · Status since Mar 202602546582Cancelled Pre Market
NORDIMET (20 MG)Nordic Group B.V. · Status since Mar 202602546590Cancelled Post Market
NORDIMET (22.5 MG)Nordic Group B.V. · Status since Mar 202602546604Cancelled Pre Market
NORDIMET (25 MG)Nordic Group B.V. · Status since Mar 202602546612Cancelled Post Market
RATIO-METHOTREXATE SODIUM (2.5 MG)Teva Canada Limited · Status since May 201802244798Cancelled Post Market
RHEUMATREX-TAB 2.5MG (2.5 MG)Wyeth-Ayerst Canada Inc. · Status since Aug 200002171767Cancelled Post Market

Notices of Compliance

Approvals of drug submissions that list it, newest first.